1. Academic Validation
  2. Unprecedented citrinin trimer tricitinol B functions as a novel topoisomerase IIα inhibitor

Unprecedented citrinin trimer tricitinol B functions as a novel topoisomerase IIα inhibitor

  • J Med Chem. 2011 Aug 25;54(16):5796-810. doi: 10.1021/jm200511x.
Lin Du 1 Hong-Chun Liu Wei Fu De-Hai Li Qiu-Ming Pan Tian-Jiao Zhu Mei-Yu Geng Qian-Qun Gu
Affiliations

Affiliation

  • 1 Key laboratory of Marine Drugs, the Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, PR China.
Abstract

Fifteen citrinin derivatives (1-4, 6-16), including two unprecedented citrinin trimers tricitrinols A (3) and B (4), were isolated from Penicillium citrinum HGY1-5. The six-membered ring A system is essential for the cytotoxicity of active dimers (1, 2, and 5) and trimers (3 and 4). Tricitrinol B (4) showed extensive cytotoxicity in 17 tumor cells with comparable low-micromolar IC(50) values (1-10 μM) and potential antimultidrug resistance capabilities. Tricitrinol B (4) induced cell Apoptosis in HL60 and HCT116 cells via mainly extrinsic pathways and G2/M arrest. Further antitumor mechanism study and computational docking analysis indicated that tricitrinol B (4) works as an intercalating Topoisomerase IIα (topo IIα) poison, which inhibits the Enzyme activity of topo IIα by interfering predominantly with the topo IIα-mediated poststrand-passage cleavage/religation equilibrium over with the prestrand-passage one and induced DNA damage. Tricitrinol B (4) represents a novel class of topo IIα-inhibitory skeletons for developing new chemotherapeutic agents.

Figures